Autopsy report · NCT00839488

Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer Prophylaxis

“the chief of GS left the hopsital and the successor did't want to keep on this study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months after it had already started.
• Ran for about 1 year before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Far Eastern Memorial Hospital

Sponsor type

University, hospital or other

Conditions

Stomach Ulcer

Interventions

pantoprazole 40 mg iv; famotidine 20 mg iv

Participants

6

Sites

1

Countries

Taiwan

Trials that died the same way

• Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
  “The study was terminated due to a change in GSK's R\&D priorities.” (59% match in meaning)
• Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia
  “The study did not start as a key co-investigator left the institution.” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.